Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.

TitleAtazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.
Publication TypeJournal Article
Year of Publication2011
AuthorsDaar ES, Tierney C, Fischl MA, Sax PE, Mollan K, Budhathoki C, Godfrey C, Jahed NC, Myers L, Katzenstein D, Farajallah A, Rooney JF, Pappa KA, Woodward WC, Patterson K, Bolivar H, Benson CA, Collier AC
Corporate AuthorsAIDS Clinical Trials Group Study A5202 Team
JournalAnn Intern Med
Volume154
Issue7
Pagination445-56
Date Published2011 Apr 5
ISSN1539-3704
KeywordsAdolescent, Adult, Atazanavir Sulfate, Benzoxazines, CD4 Lymphocyte Count, Drug Resistance, Viral, Drug Therapy, Combination, Female, HIV Infections, HIV Protease Inhibitors, HIV-1, Humans, Male, Medication Adherence, Middle Aged, Oligopeptides, Pyridines, Ritonavir, Viral Load, Young Adult
Abstract

BACKGROUND: Limited data compare once-daily options for initial therapy for HIV-1.

OBJECTIVE: To compare time to virologic failure; first grade-3 or -4 sign, symptom, or laboratory abnormality (safety); and change or discontinuation of regimen (tolerability) for atazanavir plus ritonavir with efavirenz-containing initial therapy for HIV-1.

DESIGN: A randomized equivalence trial accrued from September 2005 to November 2007, with median follow-up of 138 weeks. Regimens were assigned by using a central computer, stratified by screening HIV-1 RNA level less than 100 000 copies/mL or 100 000 copies/mL or greater; blinding was known only to the site pharmacist. (ClinicalTrials.gov registration number: NCT00118898)

SETTING: 59 AIDS Clinical Trials Group sites in the United States and Puerto Rico.

PATIENTS: Antiretroviral-naive patients.

INTERVENTION: Open-label atazanavir plus ritonavir or efavirenz, each given with with placebo-controlled abacavir-lamivudine or tenofovir disoproxil fumarate (DF)-emtricitabine.

MEASUREMENTS: Primary outcomes were time to virologic failure, safety, and tolerability events. Secondary end points included proportion of patients with HIV-1 RNA level less than 50 copies/mL, emergence of drug resistance, changes in CD4 cell counts, calculated creatinine clearance, and lipid levels.

RESULTS: 463 eligible patients were randomly assigned to receive atazanavir plus ritonavir and 465 were assigned to receive efavirenz, both with abacavir-lamivudine; 322 (70%) and 324 (70%), respectively, completed follow-up. The respective numbers of participants in each group who received tenofovir DF-emtricitabine were 465 and 464; 342 (74%) and 343 (74%) completed follow-up. Primary efficacy was similar in the group that received atazanavir plus ritonavir and and the group that received efavirenz and did not differ according to whether abacavir-lamivudine or tenofovir DF-emtricitabine was also given. Hazard ratios for time to virologic failure were 1.13 (95% CI, 0.82 to 1.56) and 1.01 (CI, 0.70 to 1.46), respectively, although CIs did not meet prespecified criteria for equivalence. The time to safety (P = 0.048) and tolerability (P < 0.001) events was longer in persons given atazanavir plus ritonavir than in those given efavirenz with abacavir-lamivudine but not with tenofovir DF-emtricitabine.

LIMITATIONS: Neither HLA-B*5701 nor resistance testing was the standard of care when A5202 enrolled patients. The third drugs, atazanavir plus ritonavir and efavirenz, were open-label; the nucleoside reverse transcriptase inhibitors were prematurely unblinded in the high viral load stratum; and 32% of patients modified or discontinued treatment with their third drug.

CONCLUSION: Atazanavir plus ritonavir and efavirenz have similar antiviral activity when used with abacavir-lamivudine or tenofovir DF-emtricitabine.

PRIMARY FUNDING SOURCE: National Institutes of Health.

DOI10.7326/0003-4819-154-7-201104050-00316
Alternate JournalAnn. Intern. Med.
PubMed ID21320923
PubMed Central IDPMC3430716
Grant List1U01 A1069423-01 / / PHS HHS / United States
1U01 AI069472-01 / AI / NIAID NIH HHS / United States
1U01 AI069494-01 / AI / NIAID NIH HHS / United States
1U01 AI069502-01 / AI / NIAID NIH HHS / United States
1U01 AI69467-01 / AI / NIAID NIH HHS / United States
1UL1 RR024156 / RR / NCRR NIH HHS / United States
1UL1 RR025777-01 / RR / NCRR NIH HHS / United States
1UO1 AI069494-01 / AI / NIAID NIH HHS / United States
3U01 AI046376 05S4 / AI / NIAID NIH HHS / United States
5P30 AI045008-10 / AI / NIAID NIH HHS / United States
5U01 A1027658 / / PHS HHS / United States
5U01 AI069415-03 / AI / NIAID NIH HHS / United States
5U01 AI069418 / AI / NIAID NIH HHS / United States
5U01 AI069428 / AI / NIAID NIH HHS / United States
5U01 AI069447 / AI / NIAID NIH HHS / United States
5U01 AI069470 / AI / NIAID NIH HHS / United States
5U01 AI069470-03 / AI / NIAID NIH HHS / United States
5U01 AI069471 / AI / NIAID NIH HHS / United States
5U01 AI069484-02 / AI / NIAID NIH HHS / United States
AI032782 / AI / NIAID NIH HHS / United States
AI069424 / AI / NIAID NIH HHS / United States
AI069434 / AI / NIAID NIH HHS / United States
AI069439 / AI / NIAID NIH HHS / United States
AI069471 / AI / NIAID NIH HHS / United States
AI069472 / AI / NIAID NIH HHS / United States
AI069474 / AI / NIAID NIH HHS / United States
AI069477 / AI / NIAID NIH HHS / United States
AI069495 / AI / NIAID NIH HHS / United States
AI069501 / AI / NIAID NIH HHS / United States
AI069513 / AI / NIAID NIH HHS / United States
AI069532 / AI / NIAID NIH HHS / United States
AI073961 / AI / NIAID NIH HHS / United States
AI25868 / AI / NIAID NIH HHS / United States
AI27661 / AI / NIAID NIH HHS / United States
AI27666 / AI / NIAID NIH HHS / United States
AI27675 / AI / NIAID NIH HHS / United States
AI34853 / AI / NIAID NIH HHS / United States
AI38855 / AI / NIAID NIH HHS / United States
AI38858 / AI / NIAID NIH HHS / United States
AI46370 / AI / NIAID NIH HHS / United States
AI50410 / AI / NIAID NIH HHS / United States
AI58740 / AI / NIAID NIH HHS / United States
AI68634 / AI / NIAID NIH HHS / United States
AI69419 / AI / NIAID NIH HHS / United States
AI69423 / AI / NIAID NIH HHS / United States
AI69432 / AI / NIAID NIH HHS / United States
AI69465 / AI / NIAID NIH HHS / United States
AI69501 / AI / NIAID NIH HHS / United States
AI69556 / AI / NIAID NIH HHS / United States
M01 RR000046 / RR / NCRR NIH HHS / United States
M01 RR000046-41 / RR / NCRR NIH HHS / United States
N01 AI72626 / AI / NIAID NIH HHS / United States
P30 AI027757 / AI / NIAID NIH HHS / United States
P30 AI045008 / AI / NIAID NIH HHS / United States
P30 AI045008-10 / AI / NIAID NIH HHS / United States
P30 AI050409 / AI / NIAID NIH HHS / United States
P30 AI050410 / AI / NIAID NIH HHS / United States
P30 AI050410-14 / AI / NIAID NIH HHS / United States
P30 AI073961 / AI / NIAID NIH HHS / United States
P30 AI073961-05 / AI / NIAID NIH HHS / United States
R01 AI058740 / AI / NIAID NIH HHS / United States
R01 AI058740-09 / AI / NIAID NIH HHS / United States
RR00046 / RR / NCRR NIH HHS / United States
RR024996 / RR / NCRR NIH HHS / United States
RR025747 / RR / NCRR NIH HHS / United States
RR025780 / RR / NCRR NIH HHS / United States
U01 AI025859-18 / AI / NIAID NIH HHS / United States
U01 AI025868 / AI / NIAID NIH HHS / United States
U01 AI025868-18 / AI / NIAID NIH HHS / United States
U01 AI027658-18 / AI / NIAID NIH HHS / United States
U01 AI027661-18 / AI / NIAID NIH HHS / United States
U01 AI027661-19 / AI / NIAID NIH HHS / United States
U01 AI027666-18 / AI / NIAID NIH HHS / United States
U01 AI032782-13 / AI / NIAID NIH HHS / United States
U01 AI034853 / AI / NIAID NIH HHS / United States
U01 AI034853-12 / AI / NIAID NIH HHS / United States
U01 AI038858 / AI / NIAID NIH HHS / United States
U01 AI038858-05 / AI / NIAID NIH HHS / United States
U01 AI046370-05 / AI / NIAID NIH HHS / United States
U01 AI046376 / AI / NIAID NIH HHS / United States
U01 AI046376-05S4 / AI / NIAID NIH HHS / United States
U01 AI068634 / AI / NIAID NIH HHS / United States
U01 AI068634-05 / AI / NIAID NIH HHS / United States
U01 AI068636-05 / AI / NIAID NIH HHS / United States
U01 AI069415-03 / AI / NIAID NIH HHS / United States
U01 AI069418 / AI / NIAID NIH HHS / United States
U01 AI069418-05 / AI / NIAID NIH HHS / United States
U01 AI069419 / AI / NIAID NIH HHS / United States
U01 AI069419-05 / AI / NIAID NIH HHS / United States
U01 AI069423 / AI / NIAID NIH HHS / United States
U01 AI069423-05 / AI / NIAID NIH HHS / United States
U01 AI069424 / AI / NIAID NIH HHS / United States
U01 AI069424-05 / AI / NIAID NIH HHS / United States
U01 AI069428 / AI / NIAID NIH HHS / United States
U01 AI069428-05 / AI / NIAID NIH HHS / United States
U01 AI069432 / AI / NIAID NIH HHS / United States
U01 AI069432-05 / AI / NIAID NIH HHS / United States
U01 AI069439 / AI / NIAID NIH HHS / United States
U01 AI069439-05 / AI / NIAID NIH HHS / United States
U01 AI069447 / AI / NIAID NIH HHS / United States
U01 AI069447-03 / AI / NIAID NIH HHS / United States
U01 AI069452 / AI / NIAID NIH HHS / United States
U01 AI069452-03 / AI / NIAID NIH HHS / United States
U01 AI069452-03 / AI / NIAID NIH HHS / United States
U01 AI069467 / AI / NIAID NIH HHS / United States
U01 AI069467-01 / AI / NIAID NIH HHS / United States
U01 AI069467-03 / AI / NIAID NIH HHS / United States
U01 AI069467-03 / AI / NIAID NIH HHS / United States
U01 AI069470 / AI / NIAID NIH HHS / United States
U01 AI069470-03 / AI / NIAID NIH HHS / United States
U01 AI069470-05 / AI / NIAID NIH HHS / United States
U01 AI069471 / AI / NIAID NIH HHS / United States
U01 AI069471-05 / AI / NIAID NIH HHS / United States
U01 AI069472 / AI / NIAID NIH HHS / United States
U01 AI069472-01 / AI / NIAID NIH HHS / United States
U01 AI069472-03 / AI / NIAID NIH HHS / United States
U01 AI069472-05 / AI / NIAID NIH HHS / United States
U01 AI069474 / AI / NIAID NIH HHS / United States
U01 AI069474-05 / AI / NIAID NIH HHS / United States
U01 AI069477 / AI / NIAID NIH HHS / United States
U01 AI069477-05 / AI / NIAID NIH HHS / United States
U01 AI069484 / AI / NIAID NIH HHS / United States
U01 AI069484-02 / AI / NIAID NIH HHS / United States
U01 AI069494 / AI / NIAID NIH HHS / United States
U01 AI069494-01 / AI / NIAID NIH HHS / United States
U01 AI069495 / AI / NIAID NIH HHS / United States
U01 AI069495-05 / AI / NIAID NIH HHS / United States
U01 AI069501 / AI / NIAID NIH HHS / United States
U01 AI069501-05 / AI / NIAID NIH HHS / United States
U01 AI069511 / AI / NIAID NIH HHS / United States
U01 AI069511 / AI / NIAID NIH HHS / United States
U01 AI069511-06 / AI / NIAID NIH HHS / United States
U01 AI069513-05 / AI / NIAID NIH HHS / United States
U01 AI069532 / AI / NIAID NIH HHS / United States
U01 AI069532-05 / AI / NIAID NIH HHS / United States
U01 AI069556-05 / AI / NIAID NIH HHS / United States
U01AI068636 / AI / NIAID NIH HHS / United States
U54 RR023561 / RR / NCRR NIH HHS / United States
UL1 RR024156 / RR / NCRR NIH HHS / United States
UL1 RR024156-05 / RR / NCRR NIH HHS / United States
UL1 RR024160 / RR / NCRR NIH HHS / United States
UL1 RR024160 / RR / NCRR NIH HHS / United States
UL1 RR024160-05 / RR / NCRR NIH HHS / United States
UL1 RR024996 / RR / NCRR NIH HHS / United States
UL1 RR024996-05 / RR / NCRR NIH HHS / United States
UL1 RR025008 / RR / NCRR NIH HHS / United States
UL1 RR025747 / RR / NCRR NIH HHS / United States
UL1 RR025747-04 / RR / NCRR NIH HHS / United States
UL1 RR025777-01 / RR / NCRR NIH HHS / United States
UL1 TR000124 / TR / NCATS NIH HHS / United States
UL1 TR000454 / TR / NCATS NIH HHS / United States
UM1 AI069477 / AI / NIAID NIH HHS / United States
UO1 AI025859 / AI / NIAID NIH HHS / United States
UOI A106947203 / / PHS HHS / United States